ABBV · AbbVie Inc. Common Stock
View on chartInsiders & Stakes
| GONZALEZ RICHARD A Chairman of the Board and CEO | ▼ Sell | Gift | 386,479 Shares held | 3/31/2025 | View profile |
| Laura J. Schumacher Director | ▼ Sell | Tax Withholding | 248,002 Shares held | 2/25/2022 | View profile |
| Azita Saleki-Gerhardt Director | ▼ Sell | Tax Withholding | 197,794 Shares held | 2/27/2026 | View profile |
| Robert A. Michael Vice Chairman | ▼ Sell | Tax Withholding | 178,737 Shares held | 2/27/2026 | View profile |
| Michael Severino Director | ▼ Sell | Open Market | 152,103 Shares held | 5/23/2022 | View profile |
| Thomas C. Freyman Director | ▲ Buy | Grant | 127,869 Shares held | 5/8/2026 | View profile |
| Hudson Thomas J SVP, R&D and CSO | ▼ Sell | Tax Withholding | 107,267 Shares held | 2/28/2024 | View profile |
| Jeffrey Ryan Stewart EVP, Chief Commercial Officer | ▼ Sell | Tax Withholding | 83,171 Shares held | 2/27/2026 | View profile |
| Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER | ▼ Sell | Open Market | 74,430 Shares held | 8/14/2026 | View profile |
| Roopal Thakkar SVP, CMO, GLOBAL THERAPEUTICS | ▼ Sell | Tax Withholding | 52,376 Shares held | 2/27/2026 | View profile |
| TILTON GLENN F Director | ▲ Buy | Grant | 51,564 Shares held | 5/9/2025 | View profile |
| Edward J. Rapp Director | ▲ Buy | Grant | 45,964 Shares held | 5/8/2026 | View profile |
| Roxanne S. Austin Director | ▲ Buy | Grant | 39,576 Shares held | 5/8/2026 | View profile |
| Scott T. Reents EVP, CHIEF FINANCIAL OFFICER | ▼ Sell | Tax Withholding | 38,777 Shares held | 2/27/2026 | View profile |
| Alpern Robert J Director | ▲ Buy | Grant | 35,646 Shares held | 5/9/2025 | View profile |
| Sorg Elaine K. SVP, US Commercial Operations | ▼ Sell | Open Market | 35,330 Shares held | 4/25/2023 | View profile |
| Durkin Brian L VP, Controller | ▼ Sell | Tax Withholding | 33,149 Shares held | 2/28/2023 | View profile |
| Frederick H. Waddell Director | ▲ Buy | Grant | 30,076 Shares held | 5/8/2026 | View profile |
| William H.l. Burnside Director | ▲ Buy | Grant | 28,076 Shares held | 5/8/2026 | View profile |
| Strom Carrie C SVP & Pres Global Allerg Aesth | ▼ Sell | Tax Withholding | 28,024 Shares held | 5/11/2023 | View profile |
| Brett J. Hart President | ▲ Buy | Grant | 20,590 Shares held | 5/8/2026 | View profile |
| Melody B. Meyer Director | ▲ Buy | Grant | 17,616 Shares held | 5/8/2026 | View profile |
| Gosebruch Henry O Director | ▼ Sell | Open Market | 16,623 Shares held | 5/16/2022 | View profile |
| Rebecca B. Roberts Director | ▲ Buy | Grant | 14,846 Shares held | 5/8/2026 | View profile |
| Demetris D. Crum EVP, CHIEF HR OFFICER | ▼ Sell | Tax Withholding | 7,914 Shares held | 2/27/2026 | View profile |
| Buckbee Kevin K SVP, CONTROLLER | ▼ Sell | Tax Withholding | 7,797 Shares held | 2/28/2025 | View profile |
| RICHMOND TIMOTHY J. EVP, Chief HR Officer | ▼ Sell | Open Market | 6,130 Shares held | 3/3/2025 | View profile |
| Perry C. Siatis EVP, GC AND SECRETARY | ▼ Sell | Open Market | 4,619 Shares held | 3/2/2026 | View profile |
| Susan E. Quaggin | ▲ Buy | Grant | 3,643 Shares held | 5/8/2026 | View profile |
| Jennifer L. Davis | ▲ Buy | Grant | 3,643 Shares held | 5/8/2026 | View profile |
| David Ryan Purdue SVP, Controller | ▼ Sell | Open Market | 2,654 Shares held | 3/4/2026 | View profile |
| Thomas J. Falk | ▲ Buy | Grant | 2,321 Shares held | 5/8/2026 | View profile |
Transaction History
| Nicholas Donoghoe | ▲ Buy | Option Exercise | 32,710 | $2.6M | 8/14/2026 |
| Nicholas Donoghoe | ▼ Sell | Open Market | 32,710 | $8.2M | 8/14/2026 |
| Frederick H. Waddell | ▲ Buy | Grant | 1,118 | $0 | 5/8/2026 |
| Rebecca B. Roberts | ▲ Buy | Grant | 1,118 | $0 | 5/8/2026 |
| Edward J. Rapp | ▲ Buy | Grant | 1,118 | $0 | 5/8/2026 |
| Susan E. Quaggin | ▲ Buy | Grant | 1,118 | $0 | 5/8/2026 |
| Melody B. Meyer | ▲ Buy | Grant | 1,118 | $0 | 5/8/2026 |
| Brett J. Hart | ▲ Buy | Grant | 1,118 | $0 | 5/8/2026 |
| Thomas C. Freyman | ▲ Buy | Grant | 1,118 | $0 | 5/8/2026 |
| Jennifer L. Davis | ▲ Buy | Grant | 1,118 | $0 | 5/8/2026 |
| Thomas J. Falk | ▲ Buy | Grant | 1,118 | $0 | 5/8/2026 |
| William H.l. Burnside | ▲ Buy | Grant | 1,118 | $0 | 5/8/2026 |
| Roxanne S. Austin | ▲ Buy | Grant | 1,118 | $0 | 5/8/2026 |
| David Ryan Purdue | ▼ Sell | Open Market | 5,230 | $1.2M | 3/4/2026 |
| Perry C. Siatis | ▼ Sell | Open Market | 5,777 | $1.3M | 3/2/2026 |
| Perry C. Siatis | ▼ Sell | Open Market | 10,291 | $2.4M | 3/2/2026 |
| Perry C. Siatis | ▼ Sell | Open Market | 2,600 | $612K | 3/2/2026 |
| Demetris D. Crum | ▼ Sell | Tax Withholding | 1,594 | $370K | 2/27/2026 |
| Roopal Thakkar | ▼ Sell | Tax Withholding | 8,037 | $1.9M | 2/27/2026 |
| Robert A. Michael | ▼ Sell | Tax Withholding | 36,523 | $8.5M | 2/27/2026 |
| Jeffrey Ryan Stewart | ▼ Sell | Tax Withholding | 23,812 | $5.5M | 2/27/2026 |
| Perry C. Siatis | ▼ Sell | Tax Withholding | 14,850 | $3.4M | 2/27/2026 |
| Scott T. Reents | ▼ Sell | Tax Withholding | 21,638 | $5.0M | 2/27/2026 |
| David Ryan Purdue | ▼ Sell | Tax Withholding | 2,692 | $625K | 2/27/2026 |
| Azita Saleki-Gerhardt | ▼ Sell | Tax Withholding | 16,309 | $3.8M | 2/27/2026 |
| Nicholas Donoghoe | ▼ Sell | Tax Withholding | 12,874 | $3.0M | 2/27/2026 |
| Perry C. Siatis | ▲ Buy | Option Exercise | 7,314 | $1.1M | 2/25/2026 |
| Perry C. Siatis | ▲ Buy | Option Exercise | 7,775 | $1.4M | 2/25/2026 |
| Perry C. Siatis | ▲ Buy | Option Exercise | 7,292 | $1.4M | 2/25/2026 |
| Perry C. Siatis | ▼ Sell | Open Market | 22,381 | $5.1M | 2/25/2026 |
| Robert A. Michael | ▲ Buy | Grant | 14,452 | $0 | 2/18/2026 |
| Perry C. Siatis | ▲ Buy | Grant | 5,808 | $0 | 2/18/2026 |
| Roopal Thakkar | ▲ Buy | Grant | 6,015 | $0 | 2/18/2026 |
| Roopal Thakkar | ▲ Buy | Grant | 2,138 | $0 | 2/18/2026 |
| Roopal Thakkar | ▲ Buy | Grant | 3,346 | $0 | 2/18/2026 |
| Roopal Thakkar | ▲ Buy | Grant | 6,638 | $0 | 2/18/2026 |
| David Ryan Purdue | ▲ Buy | Grant | 2,505 | $0 | 2/18/2026 |
| David Ryan Purdue | ▲ Buy | Grant | 890 | $0 | 2/18/2026 |
| David Ryan Purdue | ▲ Buy | Grant | 1,292 | $0 | 2/18/2026 |
| David Ryan Purdue | ▲ Buy | Grant | 1,384 | $0 | 2/18/2026 |
| Jeffrey Ryan Stewart | ▲ Buy | Grant | 9,266 | $0 | 2/18/2026 |
| Perry C. Siatis | ▲ Buy | Grant | 16,290 | $0 | 2/18/2026 |
| Perry C. Siatis | ▲ Buy | Grant | 5,792 | $0 | 2/18/2026 |
| Azita Saleki-Gerhardt | ▲ Buy | Grant | 6,058 | $0 | 2/18/2026 |
| Azita Saleki-Gerhardt | ▲ Buy | Grant | 7,074 | $0 | 2/18/2026 |
| Nicholas Donoghoe | ▲ Buy | Grant | 6,222 | $0 | 2/18/2026 |
| Azita Saleki-Gerhardt | ▲ Buy | Grant | 6,638 | $0 | 2/18/2026 |
| Demetris D. Crum | ▲ Buy | Grant | 1,244 | $0 | 2/18/2026 |
| Scott T. Reents | ▲ Buy | Grant | 25,062 | $0 | 2/18/2026 |
| Scott T. Reents | ▲ Buy | Grant | 8,910 | $0 | 2/18/2026 |
| Scott T. Reents | ▲ Buy | Grant | 7,606 | $0 | 2/18/2026 |
| Scott T. Reents | ▲ Buy | Grant | 7,260 | $0 | 2/18/2026 |
| Robert A. Michael | ▲ Buy | Grant | 33,833 | $0 | 2/18/2026 |
| Robert A. Michael | ▲ Buy | Grant | 12,030 | $0 | 2/18/2026 |
| Robert A. Michael | ▲ Buy | Grant | 22,124 | $0 | 2/18/2026 |
| Jeffrey Ryan Stewart | ▲ Buy | Grant | 26,063 | $0 | 2/18/2026 |
| Jeffrey Ryan Stewart | ▲ Buy | Grant | 9,432 | $0 | 2/18/2026 |
| Jeffrey Ryan Stewart | ▲ Buy | Grant | 8,988 | $0 | 2/18/2026 |
| Perry C. Siatis | ▲ Buy | Grant | 5,628 | $0 | 2/18/2026 |
| Azita Saleki-Gerhardt | ▲ Buy | Grant | 17,041 | $0 | 2/18/2026 |
| Demetris D. Crum | ▲ Buy | Grant | 1,216 | $0 | 2/18/2026 |
| Nicholas Donoghoe | ▲ Buy | Grant | 13,031 | $0 | 2/18/2026 |
| Nicholas Donoghoe | ▲ Buy | Grant | 4,632 | $0 | 2/18/2026 |
| Nicholas Donoghoe | ▲ Buy | Grant | 5,172 | $0 | 2/18/2026 |
| Azita Saleki-Gerhardt | ▲ Buy | Option Exercise | 42,370 | $2.3M | 8/12/2025 |
| Azita Saleki-Gerhardt | ▼ Sell | Open Market | 42,370 | $8.4M | 8/12/2025 |
| Nicholas Donoghoe | ▼ Sell | Open Market | 3,234 | $641K | 8/5/2025 |
| Nicholas Donoghoe | ▼ Sell | Open Market | 10,061 | $2.0M | 8/5/2025 |
| Thomas J. Falk | ▲ Buy | Grant | 1,203 | $0 | 5/9/2025 |
| TILTON GLENN F | ▲ Buy | Grant | 1,203 | $0 | 5/9/2025 |
| Thomas C. Freyman | ▲ Buy | Grant | 1,203 | $0 | 5/9/2025 |
| Frederick H. Waddell | ▲ Buy | Grant | 1,203 | $0 | 5/9/2025 |
| Rebecca B. Roberts | ▲ Buy | Grant | 1,203 | $0 | 5/9/2025 |
| Susan E. Quaggin | ▲ Buy | Grant | 1,203 | $0 | 5/9/2025 |
| Melody B. Meyer | ▲ Buy | Grant | 1,203 | $0 | 5/9/2025 |
| Brett J. Hart | ▲ Buy | Grant | 1,203 | $0 | 5/9/2025 |
| Jennifer L. Davis | ▲ Buy | Grant | 1,203 | $0 | 5/9/2025 |
| William H.l. Burnside | ▲ Buy | Grant | 1,203 | $0 | 5/9/2025 |
| Roxanne S. Austin | ▲ Buy | Grant | 1,203 | $0 | 5/9/2025 |
| Alpern Robert J | ▲ Buy | Grant | 1,203 | $0 | 5/9/2025 |
| Edward J. Rapp | ▲ Buy | Grant | 1,203 | $0 | 5/9/2025 |
| Jeffrey Ryan Stewart | ▲ Buy | Option Exercise | 25,700 | $2.0M | 3/31/2025 |
| GONZALEZ RICHARD A | ▼ Sell | Gift | 2,450 | $0 | 3/31/2025 |
| Jeffrey Ryan Stewart | ▼ Sell | Open Market | 25,700 | $5.4M | 3/31/2025 |
| Jeffrey Ryan Stewart | ▼ Sell | Open Market | 33,132 | $7.0M | 3/31/2025 |
| Scott T. Reents | ▼ Sell | Open Market | 17,644 | $3.7M | 3/14/2025 |
| Perry C. Siatis | ▲ Buy | Option Exercise | 7,315 | $1.1M | 3/3/2025 |
| Perry C. Siatis | ▼ Sell | Open Market | 18,008 | $3.8M | 3/3/2025 |
| RICHMOND TIMOTHY J. | ▼ Sell | Open Market | 5,677 | $1.2M | 3/3/2025 |
| RICHMOND TIMOTHY J. | ▼ Sell | Open Market | 14,973 | $3.2M | 3/3/2025 |
| Perry C. Siatis | ▲ Buy | Option Exercise | 7,775 | $1.4M | 3/3/2025 |
| RICHMOND TIMOTHY J. | ▼ Sell | Open Market | 600 | $127K | 3/3/2025 |
| GONZALEZ RICHARD A | ▼ Sell | Open Market | 6,168 | $1.3M | 3/3/2025 |
| Perry C. Siatis | ▲ Buy | Option Exercise | 2,918 | $422K | 3/3/2025 |
| Buckbee Kevin K | ▼ Sell | Tax Withholding | 3,699 | $758K | 2/28/2025 |
| Jeffrey Ryan Stewart | ▼ Sell | Tax Withholding | 20,226 | $4.1M | 2/28/2025 |
| RICHMOND TIMOTHY J. | ▼ Sell | Tax Withholding | 16,904 | $3.5M | 2/28/2025 |
| Roopal Thakkar | ▼ Sell | Tax Withholding | 4,678 | $959K | 2/28/2025 |
| Nicholas Donoghoe | ▼ Sell | Tax Withholding | 11,230 | $2.3M | 2/28/2025 |
| GONZALEZ RICHARD A | ▼ Sell | Tax Withholding | 73,209 | $15.0M | 2/28/2025 |
| GONZALEZ RICHARD A | ▼ Sell | Open Market | 92,460 | $19.0M | 2/28/2025 |
| Scott T. Reents | ▼ Sell | Tax Withholding | 10,973 | $2.2M | 2/28/2025 |
| Robert A. Michael | ▼ Sell | Tax Withholding | 27,186 | $5.6M | 2/28/2025 |
| Azita Saleki-Gerhardt | ▼ Sell | Tax Withholding | 17,056 | $3.5M | 2/28/2025 |
| Perry C. Siatis | ▼ Sell | Tax Withholding | 7,870 | $1.6M | 2/28/2025 |
| Perry C. Siatis | ▼ Sell | Open Market | 2,718 | $558K | 2/28/2025 |
| Perry C. Siatis | ▼ Sell | Open Market | 6,811 | $1.4M | 2/28/2025 |
| Perry C. Siatis | ▼ Sell | Open Market | 363 | $75K | 2/28/2025 |
| Buckbee Kevin K | ▼ Sell | Open Market | 2,684 | $546K | 2/26/2025 |
| Buckbee Kevin K | ▲ Buy | Option Exercise | 9,738 | $911K | 2/26/2025 |
| Buckbee Kevin K | ▲ Buy | Option Exercise | 6,522 | $691K | 2/26/2025 |
| Buckbee Kevin K | ▼ Sell | Open Market | 16,260 | $3.3M | 2/26/2025 |
| RICHMOND TIMOTHY J. | ▼ Sell | Open Market | 1,400 | $283K | 2/26/2025 |
| RICHMOND TIMOTHY J. | ▼ Sell | Open Market | 4,781 | $970K | 2/26/2025 |
| RICHMOND TIMOTHY J. | ▼ Sell | Open Market | 1,526 | $311K | 2/26/2025 |
| RICHMOND TIMOTHY J. | ▲ Buy | Option Exercise | 22,210 | $2.5M | 2/26/2025 |
| RICHMOND TIMOTHY J. | ▼ Sell | Open Market | 4,308 | $870K | 2/26/2025 |
| RICHMOND TIMOTHY J. | ▼ Sell | Open Market | 13,073 | $2.7M | 2/26/2025 |
| RICHMOND TIMOTHY J. | ▼ Sell | Open Market | 4,829 | $983K | 2/26/2025 |
| Perry C. Siatis | ▼ Sell | Open Market | 1,784 | $352K | 2/20/2025 |
| Perry C. Siatis | ▼ Sell | Open Market | 3,994 | $791K | 2/20/2025 |
| Jeffrey Ryan Stewart | ▲ Buy | Grant | 9,432 | $0 | 2/13/2025 |
| Perry C. Siatis | ▲ Buy | Grant | 5,792 | $0 | 2/13/2025 |
| Perry C. Siatis | ▲ Buy | Grant | 5,630 | $0 | 2/13/2025 |
| Azita Saleki-Gerhardt | ▲ Buy | Grant | 17,986 | $0 | 2/13/2025 |
| Azita Saleki-Gerhardt | ▲ Buy | Grant | 6,060 | $0 | 2/13/2025 |
| Azita Saleki-Gerhardt | ▲ Buy | Grant | 7,074 | $0 | 2/13/2025 |
| RICHMOND TIMOTHY J. | ▲ Buy | Grant | 7,378 | $0 | 2/13/2025 |
| RICHMOND TIMOTHY J. | ▲ Buy | Grant | 6,998 | $0 | 2/13/2025 |
| Scott T. Reents | ▲ Buy | Grant | 5,845 | $0 | 2/13/2025 |
| Scott T. Reents | ▲ Buy | Grant | 2,398 | $0 | 2/13/2025 |
| Scott T. Reents | ▲ Buy | Grant | 7,608 | $0 | 2/13/2025 |
| Nicholas Donoghoe | ▲ Buy | Grant | 4,634 | $0 | 2/13/2025 |
| Nicholas Donoghoe | ▲ Buy | Grant | 5,174 | $0 | 2/13/2025 |
| Robert A. Michael | ▲ Buy | Grant | 12,030 | $0 | 2/13/2025 |
| Robert A. Michael | ▲ Buy | Grant | 10,146 | $0 | 2/13/2025 |
| Azita Saleki-Gerhardt | ▲ Buy | Grant | 7,378 | $0 | 2/13/2025 |
| Nicholas Donoghoe | ▲ Buy | Grant | 4,520 | $0 | 2/13/2025 |
| RICHMOND TIMOTHY J. | ▲ Buy | Grant | 17,986 | $0 | 2/13/2025 |
| Robert A. Michael | ▲ Buy | Grant | 24,732 | $0 | 2/13/2025 |
| Nicholas Donoghoe | ▲ Buy | Grant | 11,017 | $0 | 2/13/2025 |
| Jeffrey Ryan Stewart | ▲ Buy | Grant | 7,840 | $0 | 2/13/2025 |
| RICHMOND TIMOTHY J. | ▲ Buy | Grant | 5,792 | $0 | 2/13/2025 |
| Perry C. Siatis | ▲ Buy | Grant | 4,496 | $0 | 2/13/2025 |
| Jeffrey Ryan Stewart | ▲ Buy | Grant | 19,111 | $0 | 2/13/2025 |
| Roopal Thakkar | ▲ Buy | Grant | 3,348 | $0 | 2/13/2025 |
| Jeffrey Ryan Stewart | ▲ Buy | Grant | 9,268 | $0 | 2/13/2025 |
| Scott T. Reents | ▲ Buy | Grant | 8,912 | $0 | 2/13/2025 |
| Buckbee Kevin K | ▲ Buy | Grant | 1,674 | $0 | 2/13/2025 |
| Buckbee Kevin K | ▲ Buy | Grant | 3,595 | $0 | 2/13/2025 |
| Buckbee Kevin K | ▲ Buy | Grant | 1,474 | $0 | 2/13/2025 |
| Buckbee Kevin K | ▲ Buy | Grant | 1,604 | $0 | 2/13/2025 |
| Roopal Thakkar | ▲ Buy | Grant | 3,595 | $0 | 2/13/2025 |
| Roopal Thakkar | ▲ Buy | Grant | 1,474 | $0 | 2/13/2025 |
| Roopal Thakkar | ▲ Buy | Grant | 2,138 | $0 | 2/13/2025 |
| GONZALEZ RICHARD A | ▲ Buy | Grant | 80,945 | $0 | 2/13/2025 |
| GONZALEZ RICHARD A | ▲ Buy | Grant | 33,208 | $0 | 2/13/2025 |
| GONZALEZ RICHARD A | ▲ Buy | Grant | 30,298 | $0 | 2/13/2025 |
| GONZALEZ RICHARD A | ▲ Buy | Grant | 27,386 | $0 | 2/13/2025 |
| Robert A. Michael | ▲ Buy | Grant | 14,454 | $0 | 2/13/2025 |
| Perry C. Siatis | ▲ Buy | Grant | 1,844 | $0 | 2/13/2025 |
| Buckbee Kevin K | ▲ Buy | Option Exercise | 1,800 | $168K | 12/16/2024 |
| Buckbee Kevin K | ▼ Sell | Open Market | 1,800 | $310K | 12/16/2024 |
| GONZALEZ RICHARD A | ▼ Sell | Gift | 5,243 | $0 | 9/30/2024 |
| GONZALEZ RICHARD A | ▼ Sell | Gift | 15,729 | $0 | 9/30/2024 |
| GONZALEZ RICHARD A | ▼ Sell | Gift | 36,698 | $0 | 9/30/2024 |
| Azita Saleki-Gerhardt | ▼ Sell | Gift | 25,630 | $0 | 9/24/2024 |
| GONZALEZ RICHARD A | ▼ Sell | Open Market | 66,500 | $12.4M | 8/5/2024 |
| GONZALEZ RICHARD A | ▲ Buy | Option Exercise | 87,050 | $5.3M | 7/17/2024 |
| GONZALEZ RICHARD A | ▲ Buy | Option Exercise | 119,418 | $9.4M | 7/17/2024 |
| GONZALEZ RICHARD A | ▲ Buy | Option Exercise | 76,377 | $7.1M | 7/17/2024 |
| GONZALEZ RICHARD A | ▼ Sell | Open Market | 282,845 | $49.5M | 7/17/2024 |
| GONZALEZ RICHARD A | ▼ Sell | Gift | 6,000 | $0 | 6/28/2024 |
| TILTON GLENN F | ▲ Buy | Grant | 1,322 | $0 | 5/3/2024 |
| Frederick H. Waddell | ▲ Buy | Grant | 1,322 | $0 | 5/3/2024 |
| Jennifer L. Davis | ▲ Buy | Grant | 1,322 | $0 | 5/3/2024 |
| Susan E. Quaggin | ▲ Buy | Grant | 1,322 | $0 | 5/3/2024 |
| Edward J. Rapp | ▲ Buy | Grant | 1,322 | $0 | 5/3/2024 |
| Alpern Robert J | ▲ Buy | Grant | 1,322 | $0 | 5/3/2024 |
| Thomas C. Freyman | ▲ Buy | Grant | 1,322 | $0 | 5/3/2024 |
| Roxanne S. Austin | ▲ Buy | Grant | 1,322 | $0 | 5/3/2024 |
| Brett J. Hart | ▲ Buy | Grant | 1,322 | $0 | 5/3/2024 |
| Melody B. Meyer | ▲ Buy | Grant | 1,322 | $0 | 5/3/2024 |
| Rebecca B. Roberts | ▲ Buy | Grant | 1,322 | $0 | 5/3/2024 |
| William H.l. Burnside | ▲ Buy | Grant | 1,322 | $0 | 5/3/2024 |
| Nicholas Donoghoe | ▼ Sell | Open Market | 21,082 | $3.7M | 3/20/2024 |
| Jeffrey Ryan Stewart | ▲ Buy | Option Exercise | 26,110 | $1.6M | 3/18/2024 |
| Jeffrey Ryan Stewart | ▼ Sell | Open Market | 5,099 | $913K | 3/18/2024 |
| Jeffrey Ryan Stewart | ▼ Sell | Open Market | 26,110 | $4.7M | 3/18/2024 |
| Jeffrey Ryan Stewart | ▼ Sell | Open Market | 27,740 | $5.0M | 3/18/2024 |
| RICHMOND TIMOTHY J. | ▲ Buy | Option Exercise | 45,700 | $2.8M | 3/1/2024 |
| RICHMOND TIMOTHY J. | ▼ Sell | Open Market | 15,412 | $2.7M | 3/1/2024 |
| RICHMOND TIMOTHY J. | ▼ Sell | Open Market | 30,288 | $5.4M | 3/1/2024 |
| RICHMOND TIMOTHY J. | ▼ Sell | Open Market | 9,853 | $1.7M | 3/1/2024 |
| RICHMOND TIMOTHY J. | ▼ Sell | Open Market | 20,127 | $3.6M | 3/1/2024 |
| Buckbee Kevin K | ▼ Sell | Open Market | 5,144 | $909K | 2/29/2024 |
| Robert A. Michael | ▲ Buy | Option Exercise | 10,140 | $556K | 2/29/2024 |
| Robert A. Michael | ▼ Sell | Open Market | 21,560 | $3.8M | 2/29/2024 |
| Robert A. Michael | ▼ Sell | Open Market | 47,319 | $8.3M | 2/29/2024 |
| Perry C. Siatis | ▼ Sell | Open Market | 6,504 | $1.2M | 2/29/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
AbbVie Gains from Oncology Trial News and Dividend Appeal
AbbVie’s recent oncology trial results suggest the stock may be undervalued, with a 51% risk reduction in diffuse large B‑cell lymphoma. Its 4.47% dividend yield and 16.4‑times earnings valuation attract income‑focused investors. Analysts compare AbbVie to peers like Pfizer and Merck, noting its outperformance this year. The stock sits near the top of its 52‑week range, adding context to the valuation debate.
AbbVie Gains from Oncology Trial News and Dividend Appeal. AbbVie’s recent oncology trial results suggest the stock may be undervalued, with a 51% risk reduction in diffuse large B‑cell lymphoma. Its 4.47% dividend yield and 16.4‑times earnings valuation attract income‑focused investors. Analysts compare AbbVie to peers like Pfizer and Merck, noting its outperformance this year. The stock sits near the top of its 52‑week range, adding context to the valuation debate.